Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Raw Materials (2023 - 2025)

MDxHealth (MDXH) has disclosed Raw Materials for 3 consecutive years, with $6.9 million as the latest value for Q4 2025.

  • Quarterly Raw Materials rose 78.26% to $6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Dec 2025, up 78.26% year-over-year, with the annual reading at $6.9 million for FY2025, 78.26% up from the prior year.
  • Raw Materials hit $6.9 million in Q4 2025 for MDxHealth, up from $3.9 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $6.9 million in Q4 2025 to a low of $2.8 million in Q4 2023.
  • Historically, Raw Materials has averaged $4.5 million across 3 years, with a median of $3.9 million in 2024.
  • Biggest five-year swings in Raw Materials: skyrocketed 39.22% in 2024 and later surged 78.26% in 2025.
  • Year by year, Raw Materials stood at $2.8 million in 2023, then surged by 39.22% to $3.9 million in 2024, then soared by 78.26% to $6.9 million in 2025.
  • Business Quant data shows Raw Materials for MDXH at $6.9 million in Q4 2025, $3.9 million in Q4 2024, and $2.8 million in Q4 2023.